<DOC>
	<DOCNO>NCT00730912</DOCNO>
	<brief_summary>This post marketing study confirm appropriate dose loratadine child obtain drug concentration data multiple time point per child adult patient , patient receives repeat administration approve dose loratadine .</brief_summary>
	<brief_title>Post Approval Pharmacokinetic Study Loratadine Japanese Pediatric Adult Patients ( Study P05539 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Patients perennial allergic rhinitis satisfy follow criterion enrol study : Pediatric patient age 3 15 year adult patient age 16 64 time provide informed consent . Outpatients either sex . Pediatric patient write informed consent obtain guardian start study . Adult patient write informed consent obtain ( patient age 16 19 , guardian must also provide write informed consent ) . Pediatric patient ability make entry patient diary ( Record Drugs Nasal Symptoms ) entry diary make possible guardian . Adult patient ability make entry patient diary . Patients treatment loratadine monotherapy judge appropriate base symptom allergic rhinitis pretreatment observation period . Patients confirm allergic perennial allergen Patients history epileptic seizure organic brain disorder possibility epileptic seizure may induce Patients history hypersensitivity component drug Patients pregnant may pregnant , nurse woman Patients severe hepatic , renal , cardiac , hematological disease serious complication whose general condition poor Patients participate another clinical study clinical study within last 30 day . Other patient judge inappropriate study investigator subinvestigator Patients allergic pollen ( cedar , mugwort , common ragweed , orchard grass , etc . ) pollen season period 7 day registration end study drug administration Patients develop disease might affect nasal symptom ( acute upper respiratory tract infection , acute pharyngolaryngitis , acute tonsillitis ) 7 day registration Patients receive treatment allergic rhinitis 7 day registration</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>